BBC Business
Ozempic Maker Sues Rival for Saying Its Drug Is Better, Which Is Rude
Novo Nordisk sues Eli Lilly for false advertising in weight-loss drug wars, because nothing says 'healthy competition' like a courtroom drama.
2026-07-21
BBC Business
2026-06-06
ScienceDaily
Ozempic and Friends May Add ‘Cancer Deterrent’ to Their Already Impressive Résumés
GLP-1 weight-loss drugs like Ozempic may reduce breast cancer risk by 30%, researchers say - though they’re not ready to call it a miracle cure just yet.
The Good Times
News in your inbox.
One sardonic roundup, delivered on your schedule. Free. Unsubscribe whenever your tolerance for wit runs out.
Already subscribed but we never reach your inbox? Check your spam folder and hit 'Not spam' (or 'Remove from spam') to bust us out of junk-mail purgatory. You'll be helping everyone else too.